Cite

HARVARD Citation

    T, M. et al. (2020). In-silico therapeutic investigations of arjunic acid and arjungenin as an FXR agonist and validation in 3T3-L1 adipocytes. Computational biology and chemistry. p. . [Online]. 
  
Back to record